These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1434 related items for PubMed ID: 24342167

  • 1. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S, Deodato F, Digesù C, Macchia G, Picardi V, Ferro M, Sallustio G, De Spirito M, Piermattei A, Morganti AG.
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [Abstract] [Full Text] [Related]

  • 2. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer.
    Cilla S, Caravatta L, Picardi V, Sabatino D, Macchia G, Digesù C, Deodato F, Massaccesi M, De Spirito M, Piermattei A, Morganti AG.
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):261-8. PubMed ID: 21820294
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
    Li XA, Wang JZ, Jursinic PA, Lawton CA, Wang D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1251-7. PubMed ID: 15752907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical experience transitioning from IMRT to VMAT for head and neck cancer.
    Studenski MT, Bar-Ad V, Siglin J, Cognetti D, Curry J, Tuluc M, Harrison AS.
    Med Dosim; 2013 Mar 15; 38(2):171-5. PubMed ID: 23246253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?
    Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K, Flentje M.
    Radiother Oncol; 2009 Nov 15; 93(2):259-65. PubMed ID: 19748146
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT.
    Stieler F, Wolff D, Schmid H, Welzel G, Wenz F, Lohr F.
    Radiother Oncol; 2011 Dec 15; 101(3):388-93. PubMed ID: 21962821
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
    Macchia G, Cilla S, Morganti AG, Deodato F, Legge F, Piermattei A, Chiantera V, Scambia G, Valentini V, Ferrandina G.
    Acta Oncol; 2014 Feb 15; 53(2):251-8. PubMed ID: 24050516
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases.
    Pyshniak V, Fotina I, Zverava A, Siamkouski S, Zayats E, Kopanitsa G, Okuntsau D.
    J Appl Clin Med Phys; 2014 Jul 08; 15(4):4514. PubMed ID: 25207394
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.